Karachi, Abbott Laboratories Limitedinformed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on February 26, 2018.
The agenda of the meeting was discussion of profit and loss account for year ended December 31, 2017 which portrayed a profit of Rs. 4,205,232 with earnings per share 42.95 basic and diluted respectively.
Further, 300% payment of cash dividend, bonus shares and right shares was agreed.
Furthermore, the share transfer books of the company will remain closed from April14, 2018 to April23, 2018 (both days inclusive).
Abbott Laboratories Limited is a public limited company. It was incorporated in Pakistan on July 2, 1948. Abbott started operations in Pakistan as a marketing affiliate in 1948. The company is engaged in the manufacturing, importing and marketing of research based pharmaceutical, nutritional, diagnostic, diabetic care, molecular devices, and hospital and consumer products. The company also provides toll manufacturing services. The stocks of the company are quoted on the Karachi, Lahore and Islamabad stock exchanges of Pakistan. The registered office of the company is located in Karachi.
Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago, USA. It has over 70,000 employees worldwide and a global presence in more than 130 countries. It has a work force of over 1500 employees. Besides this the company has two manufacturing facilities located at Landhi and Korangi in Karachi.
The symbol “ABOT” is being used by the stock exchanges for the shares of Abbott Laboratories Limited.